Margarita Morales-Perez

Comprehensive NeuroScience (CNS) is a strategic clinical research partner providing a full range of services in various therapeutic areas with an outstanding record for consistently delivering quality and success on time and within budget. CNS continues to dominate the therapeutic development process by standing as a strategic partner poised with expertise in central nervous system disorders and multiple therapeutic areas, research methodologies, regulatory requisites and evolving patient needs. CNS is dedicated to open and effective communication at all organizational levels, and to supporting sponsor confidence through simplified contracting, timely enrollment, proactive trial execution, and quality data delivery. CNS delivers accelerated product development that is coupled with integrated clinical trial management services and high quality investigative site research services for all phases within three separate divisions.

Comprehensive Clinical Development, Inc. provides multi therapeutic clinical research services. It engages in conducting early phase studies in Phase I-IIa for large and small biopharmaceutical, biotechnology medical device and consumer companies. The company is headquartered in Phoenix, AZ.

Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY.